| Net income (loss) | -45.51M |
| Depreciation and amortization | 20.56M |
| Stock-based compensation expense | 10.29M |
| Provision for excess and obsolete inventories | 975K |
| Accrued indemnification costs | |
| Deferred income taxes | 293K |
| Net change in operating assets and liabilities | -5.56M |
| Net cash provided by operating activities | -20.2M |
| Proceeds from sale, redemption or maturity of investment securities | |
| Purchases of investment securities | |
| Capital expenditures | -3.87M |
| Decrease in restricted cash | |
| Net cash provided by investing activities | -3.87M |
| Proceeds from the exercise of stock options and employee stock purchase plan | 4.05M |
| Net cash provided by financing activities | -1.68M |
| Effect of exchange rate changes on cash | 43K |
| Net increase in cash and cash equivalents | -25.7M |
| Cash and cash equivalents at beginning of period | 84.59M |
| Cash and cash equivalents at end of period | 58.9M |
| Cash paid for income taxes | 412K |